HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
BIIB holding history
Biogen Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BIIB overviewAll 13F holders of BIIBFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −1−100.0% | Sold out | Holders |
| Q3 2024 | 1 | $194 | <0.1% | +1 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −250−100.0% | Sold out | Holders |
| Q3 2023 | 250 | $64.3K | <0.1% | +200+400.0% | Added | Holders |
| Q2 2023 | 50 | $14.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 50 | $13.9K | <0.1% | −255−83.6% | Reduced | Holders |
| Q4 2022 | 305 | $84.5K | <0.1% | +5+1.7% | Added | Holders |
| Q3 2022 | 300 | $80.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 300 | $61.0K | <0.1% | −7−2.3% | Reduced | Holders |
| Q1 2022 | 307 | $65.0K | <0.1% | +7+2.3% | Added | Holders |
| Q4 2021 | 300 | $72.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 300 | $85.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 300 | $104.0K | <0.1% | −24−7.4% | Reduced | Holders |
| Q1 2021 | 324 | $91.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.